Original Source(s)
Related Content
FDA raises TMB threshold for pembrolizumab
Traditional approval narrows eligibility for previously treated solid tumors after efficacy was not confirmed at lower biomarker levels.
by Mouj Hijazi
October 23, 2026
-
3 min
PET/MRI may reveal MRI-occult inflammation
In a rare anti-vimentin encephalitis case, molecular imaging detected abnormalities that declined alongside neurologic improvement following immunotherapy.
October 28, 2026
-
4 min
HBV vaccine policy shift may raise infections
A modeling study projects 83% more childhood chronic hepatitis B infections and 1.8 million susceptible young adults under a shared decision-making vaccination strategy.
October 19, 2026
-
4 min